Today, I have another controversial prediction. One which I will take no pleasure in seeing come true. See, even with President Trump returning as the leader of our free country, I believe Elon Musk is in mortal danger.

I share with you in this special investigative documentary.

GALT Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 52.70%

Insider Buying (Last 12 Months): $34,100.70

Insider Selling (Last 12 Months): $65,248.38

Galectin Therapeutics Insider Trading History Chart

Galectin Therapeutics Share Price & Price History

^$2.78

▲ +0.06 (2.21%)

As of 11/22/2024 01:00 AM ET

Days: 30 | 90 | 365

“Fed Proof” Your Bank Account with THESE 4 Simple Steps

From Weiss Ratings | Ad

Starting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide. It will give them unprecedented powers to control your bank account.

Learn these 4 simple steps and protect your savings before it’s too late.

Galectin Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
10/23/2024	Kary Eldred	Director	Buy	500	$2.60	$1,300.00	50,213
10/16/2024	Kevin D. Freeman	Director	Buy	5,000	$2.70	$13,500.00	33,469
8/23/2024	Richard A. Zordani, Jr.	Director	Buy	1,759	$2.30	$4,045.70	32,083
4/30/2024	Richard A. Zordani, Jr.	Director	Buy	1,000	$3.52	$3,520.00	1,000
4/24/2024	Joel Lewis	CEO	Buy	1,000	$3.39	$3,390.00	2,000
4/22/2024	James C Czirr	Major Shareholder	Sell	21,323	$3.06	$65,248.38	5,925,884
4/22/2024	Kevin D. Freeman	Director	Buy	2,500	$2.98	$7,450.00	25,969
1/16/2024	Kary Eldred	Director	Buy	500	$1.79	$895.00	49,313
7/19/2023	Kary Eldred	Director	Buy	1,598	$1.79	$2,860.42	48,813
2/21/2023	Kary Eldred	Director	Buy	1,000	$1.59	$1,590.00	47,215
2/16/2023	Joel Lewis	CEO	Buy	1,000	$1.52	$1,520.00	1,000
1/25/2023	Kary Eldred	Director	Buy	1,300	$1.11	$1,443.00	46,215
11/17/2022	Jack W Callicutt	CFO	Buy	4,000	$1.32	$5,280.00	7,614
10/28/2022	Kevin D. Freeman	Director	Buy	10,000	$1.41	$14,100.00	75,000
7/28/2022	Richard A. Zordani, Jr.	Director	Buy	5,000	$2.50	$12,500.00	29,583
5/19/2022	Kevin D. Freeman	Director	Buy	5,000	$1.33	$6,650.00	65,000
4/18/2022	Kevin D. Freeman	Director	Buy	5,000	$1.71	$8,550.00	60,000
4/4/2022	Richard A. Zordani, Jr.	Director	Buy	5,000	$1.60	$8,000.00	24,583
2/2/2022	Fund L.P. 10X	Major Shareholder	Sell	10,000	$2.10	$21,000.00
1/21/2022	Elissa J. Schwartz	Director	Buy	1,000	$2.00	$2,000.00
1/19/2022	Kevin D. Freeman	Director	Buy	5,000	$1.96	$9,800.00
1/14/2022	Richard A. Zordani, Jr.	Director	Buy	5,000	$2.02	$10,100.00
1/11/2022	Fund L.P. 10X	Major Shareholder	Sell	10,000	$2.10	$21,000.00
12/6/2021	Kevin D. Freeman	Director	Buy	5,000	$2.34	$11,700.00
12/2/2021	Fund L.P. 10X	Major Shareholder	Sell	10,000	$2.37	$23,700.00

Trump’s Sending THIS Crypto Higher on Purpose

From Crypto 101 Media | Ad

Discover the coin set to explode before 2025! Trump could trigger THIS crypto coin…

YES, I WANT THE #1 CRYPTO NOW

SEC Filings (Institutional Ownership Changes) for Galectin Therapeutics (NASDAQ:GALT)

11.68% of Galectin Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Galectin Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/19/2024	Barclays PLC	28,587	$79K	0.0%	+309.0%	0.046%
11/18/2024	Soltis Investment Advisors LLC	140,750	$0.39M	0.0%	N/A	0.226%
11/16/2024	Geode Capital Management LLC	862,542	$2.37M	0.0%	+2.5%	1.385%
11/15/2024	Barclays PLC	28,587	$79K	0.0%	+309.0%	0.046%
11/15/2024	Kovitz Investment Group Partners LLC	42,540	$0.12M	0.0%	N/A	0.068%
11/15/2024	State Street Corp	251,014	$0.69M	0.0%	+9.3%	0.403%
11/13/2024	D.A. Davidson & CO.	30,771	$85K	0.0%	-36.9%	0.049%
10/28/2024	Gladstone Institutional Advisory LLC	21,750	$60K	0.0%	N/A	0.035%
10/21/2024	Retirement Guys Formula LLC	63,817	$0.18M	0.1%	+55.1%	0.103%
9/5/2024	Sanctuary Advisors LLC	100,658	$0.23M	0.0%	N/A	0.162%
8/14/2024	Squarepoint Ops LLC	84,074	$0.19M	0.0%	+75.4%	0.135%
8/14/2024	Marshall Wace LLP	18,825	$43K	0.0%	N/A	0.030%
8/1/2024	Rhumbline Advisers	19,275	$44K	0.0%	N/A	0.031%
7/31/2024	Commonwealth Equity Services LLC	483,351	$1.09M	0.0%	+317.6%	0.778%
7/26/2024	Bank of New York Mellon Corp	64,423	$0.15M	0.0%	N/A	0.104%
7/24/2024	Traynor Capital Management Inc.	42,871	$97K	0.0%	+23.5%	0.069%
5/10/2024	Vanguard Group Inc.	1,979,891	$4.73M	0.0%	+2.0%	3.198%
5/7/2024	Wealthspire Advisors LLC	398,374	$0.95M	0.0%	+116.7%	0.644%
5/4/2024	Geneos Wealth Management Inc.	408,850	$0.98M	0.0%	-0.9%	0.660%
4/19/2024	Retirement Guys Formula LLC	33,732	$81K	0.0%	+56.9%	0.054%
2/6/2024	Solutions 4 Wealth Ltd	36,085	$60K	0.2%	N/A	0.058%
2/2/2024	Atria Wealth Solutions Inc.	249,800	$0.42M	0.0%	-3.8%	0.404%
2/1/2024	Cutter & CO Brokerage Inc.	117,488	$0.20M	0.1%	-9.3%	0.190%
1/22/2024	Retirement Guys Formula LLC	21,500	$36K	0.0%	+87.0%	0.035%
1/9/2024	Beacon Capital Management LLC	23,905	$40K	0.0%	+89.6%	0.039%
11/8/2023	D.A. Davidson & CO.	37,825	$73K	0.0%	+15.2%	0.061%
10/16/2023	Traynor Capital Management Inc.	34,707	$67K	0.0%	N/A	0.056%
10/11/2023	AE Wealth Management LLC	26,841	$52K	0.0%	+72.7%	0.043%
8/3/2023	Atria Wealth Solutions Inc.	260,800	$0.38M	0.0%	-3.7%	0.439%
7/25/2023	Summit Trail Advisors LLC	20,000	$29K	0.0%	N/A	0.034%
7/13/2023	Cambridge Investment Research Advisors Inc.	134,332	$0.19M	0.0%	-5.7%	0.226%
5/12/2023	Independent Advisor Alliance	36,100	$76K	0.0%	N/A	0.061%
5/9/2023	Wealthspire Advisors LLC	183,862	$0.39M	0.0%	N/A	0.309%
5/9/2023	Wedbush Securities Inc.	15,498	$33K	0.0%	-36.7%	0.026%
4/25/2023	Geneos Wealth Management Inc.	427,400	$0.90M	0.1%	-1.7%	0.719%
2/7/2023	Commonwealth Equity Services LLC	101,522	$0.11M	0.0%	+165.6%	0.170%
2/7/2023	Benjamin F. Edwards & Company Inc.	34,412	$39K	0.0%	+78.7%	0.058%
2/3/2023	Cutter & CO Brokerage Inc.	129,488	$0.15M	0.0%	-23.6%	0.217%
1/31/2023	Geneos Wealth Management Inc.	434,800	$0.49M	0.0%	-2.3%	0.729%
11/7/2022	D.A. Davidson & CO.	32,810	$53K	0.0%	-27.6%	0.055%
7/28/2022	D.A. Davidson & CO.	45,335	$59K	0.0%	-18.0%	0.076%
7/19/2022	Commonwealth Equity Services LLC	38,220	$50K	0.0%	+42.1%	0.064%
5/4/2022	Advisor Group Holdings Inc.	1,265,820	$2.04M	0.0%	+1.5%	2.133%
5/4/2022	Commonwealth Equity Services LLC	26,902	$43K	0.0%	+59.2%	0.045%
5/3/2022	Cutter & CO Brokerage Inc.	169,578	$0.27M	0.1%	-7.6%	0.286%
2/9/2022	Geneos Wealth Management Inc.	480,767	$1M	0.0%	-2.2%	0.810%
2/7/2022	Benjamin F. Edwards & Company Inc.	29,615	$61K	0.0%	+25.5%	0.050%
2/7/2022	Ameritas Advisory Services LLC	44,232	$92K	0.0%	N/A	0.075%
2/3/2022	Cambridge Investment Research Advisors Inc.	153,027	$0.32M	0.0%	-7.0%	0.258%
2/3/2022	Advisor Group Holdings Inc.	1,247,401	$2.58M	0.0%	-2.1%	2.102%
11/16/2021	Squarepoint Ops LLC	39,191	$0.15M	0.0%	-30.2%	0.066%
11/15/2021	Capstone Investment Advisors LLC	42,260	$0.16M	0.0%	N/A	0.071%
11/12/2021	Ameritas Investment Company LLC	44,232	$0.17M	0.0%	+12.7%	0.075%
11/12/2021	Centaurus Financial Inc.	22,614	$88K	0.0%	+44.8%	0.038%
11/12/2021	Geode Capital Management LLC	540,866	$2.10M	0.0%	+32.2%	0.912%
11/10/2021	Buckingham Strategic Wealth LLC	10,734	$42K	0.0%	N/A	0.018%
11/9/2021	BlackRock Inc.	787,582	$3.06M	0.0%	-0.8%	1.328%
11/8/2021	Keybank National Association OH	100,000	$0.39M	0.0%	N/A	0.169%
11/4/2021	QCI Asset Management Inc. NY	55,000	$0.21M	0.0%	+120.0%	0.093%
11/2/2021	Raymond James & Associates	13,096	$51K	0.0%	N/A	0.022%
11/2/2021	Benjamin F. Edwards & Company Inc.	23,600	$92K	0.0%	-32.0%	0.040%
11/2/2021	Cambridge Investment Research Advisors Inc.	164,498	$0.64M	0.0%	-2.3%	0.277%
10/29/2021	Commonwealth Equity Services LLC	11,902	$46K	0.0%	N/A	0.020%
10/8/2021	Wedbush Securities Inc.	30,998	$0.12M	0.0%	+72.2%	0.052%
9/3/2021	Parametric Portfolio Associates LLC	56,047	$0.18M	0.0%	+62.9%	0.096%
8/25/2021	Marshall Wace LLP	47,509	$0.15M	0.0%	N/A	0.082%
8/17/2021	Millennium Management LLC	568,690	$1.82M	0.0%	N/A	0.979%
8/17/2021	Boothbay Fund Management LLC	10,965	$35K	0.0%	N/A	0.019%
8/16/2021	Squarepoint Ops LLC	56,128	$0.18M	0.0%	N/A	0.097%
8/16/2021	Ameritas Investment Company LLC	39,232	$0.13M	0.0%	N/A	0.068%
8/16/2021	LMR Partners LLP	19,285	$62K	0.0%	N/A	0.033%
8/16/2021	Charles Schwab Investment Management Inc.	17,413	$56K	0.0%	-77.5%	0.030%
8/16/2021	State Street Corp	158,759	$0.51M	0.0%	-74.2%	0.273%
8/16/2021	Tibra Equities Europe Ltd	98,700	$0.32M	0.1%	N/A	0.170%
8/16/2021	Marshall Wace LLP	47,509	$0.15M	0.0%	N/A	0.082%
8/13/2021	Renaissance Technologies LLC	370,199	$1.19M	0.0%	+20.6%	0.637%
8/13/2021	Northern Trust Corp	96,270	$0.31M	0.0%	-77.1%	0.166%
8/13/2021	LPL Financial LLC	52,034	$0.17M	0.0%	+219.5%	0.090%
8/13/2021	Geode Capital Management LLC	409,013	$1.31M	0.0%	-36.7%	0.704%
8/13/2021	Vanguard Group Inc.	1,953,419	$6.25M	0.0%	+1.1%	3.362%
8/12/2021	XTX Topco Ltd	12,419	$40K	0.0%	N/A	0.021%
8/12/2021	Ergoteles LLC	139,181	$0.45M	0.0%	N/A	0.240%
8/11/2021	Bank of New York Mellon Corp	23,080	$74K	0.0%	-76.9%	0.040%
8/11/2021	BlackRock Inc.	793,934	$2.54M	0.0%	-69.7%	1.367%
8/11/2021	Susquehanna Fundamental Investments LLC	15,600	$50K	0.0%	N/A	0.027%
8/10/2021	Cambridge Investment Research Advisors Inc.	168,316	$0.54M	0.0%	N/A	0.290%
8/10/2021	Rockefeller Capital Management L.P.	10,386	$33K	0.0%	+419.3%	0.018%
8/2/2021	Advisor Group Holdings Inc.	1,273,157	$4.07M	0.0%	+4.2%	2.192%
6/17/2021	Geneos Wealth Management Inc.	511,606	$2.26M	0.1%	+5.4%	0.881%
5/19/2021	Virtu Financial LLC	14,683	$32K	0.0%	N/A	0.026%
5/18/2021	D. E. Shaw & Co. Inc.	45,775	$99K	0.0%	-10.8%	0.080%
5/17/2021	Vivaldi Capital Management LLC	10,668	$45K	0.0%	-30.9%	0.019%
5/17/2021	Nuveen Asset Management LLC	177,035	$0.38M	0.0%	-4.2%	0.310%
5/14/2021	Occudo Quantitative Strategies LP	18,967	$41K	0.0%	N/A	0.033%
5/14/2021	Dimensional Fund Advisors LP	11,977	$26K	0.0%	N/A	0.021%
5/13/2021	Barclays PLC	31,094	$68K	0.0%	+159.0%	0.054%
5/13/2021	Renaissance Technologies LLC	307,000	$0.67M	0.0%	+1,864.5%	0.537%
5/13/2021	Neuberger Berman Group LLC	13,614	$30K	0.0%	-25.2%	0.024%
5/13/2021	Bank of New York Mellon Corp	99,901	$0.22M	0.0%	-7.0%	0.175%
5/13/2021	Bank of Montreal Can	21,329	$53K	0.0%	+272.7%	0.037%

Data available starting January 2016

Galectin Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the research and development of therapies for fibrotic, cancer, and other diseases. Its lead product candidate is belapectin (GR-MD-02) galectin-3 inhibitor, that is in Phase 2b/3 clinical trial, to prevent esophageal varices in patient with non-alcoholic steatohepatitis (NASH) cirrhosis; and Phase 2 clinical trial for the treatment of liver fibrosis, as well as severe skin disease, and melanoma and head and neck squamous cell carcinoma. The company, through its Galectin Sciences, LLC, which is a collaborative joint venture co-owned by SBH Sciences, Inc., to research and develop small organic molecule inhibitors of galectin-3 for oral administration. The company was formerly known as Pro-Pharmaceuticals, Inc. and changed its name to Galectin Therapeutics, Inc. in May 2011. Galectin Therapeutics Inc. was founded in 2000 and is based in Norcross, Georgia.

Today's Range

Now: $2.78

$2.68

$2.82

50 Day Range

MA: $2.69

$2.47

$3.00

52 Week Range

Now: $2.78

$1.55

$4.27

Volume

133,423 shs

Average Volume

153,678 shs

Market Capitalization

$174.47 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.62

Who are the company insiders with the largest holdings of Galectin Therapeutics?: Galectin Therapeutics' top insider investors include:
James C Czirr (Major Shareholder)
Kary Eldred (Director)
Kevin D Freeman (Director)
Richard A Jr Zordani (Director)
Joel Lewis (CEO)
Learn More about top insider investors at Galectin Therapeutics.
Who are the major institutional investors of Galectin Therapeutics?: Galectin Therapeutics' top institutional shareholders include:
Geode Capital Management LLC — 1.38%
Ikarian Capital LLC — 0.00%
State Street Corp — 0.40%
Soltis Investment Advisors LLC — 0.23%
Retirement Guys Formula LLC — 0.10%
Kovitz Investment Group Partners LLC — 0.07%
Learn More about top institutional investors of Galectin Therapeutics stock.
Which major investors are selling Galectin Therapeutics stock?: In the last quarter, GALT stock was sold by these institutional investors:
D.A. Davidson & CO.
Which major investors are buying Galectin Therapeutics stock?: In the last quarter, GALT stock was purchased by institutional investors including:
Ikarian Capital LLC
Soltis Investment Advisors LLC
Kovitz Investment Group Partners LLC
Retirement Guys Formula LLC
Gladstone Institutional Advisory LLC
Barclays PLC
Barclays PLC
State Street Corp
In the last year, these company insiders have bought Galectin Therapeutics stock:
James C Czirr (Major Shareholder)
Kary Eldred (Director)
Kevin D Freeman (Director)
Richard A Jr Zordani (Director)
Learn More investors buying Galectin Therapeutics stock.

First JFK… next Elon?

From Porter & Company | Ad